Bendamustine, Cytarabine, Etoposide and Melphalan (BeEAM) as Conditioning for Autologous Stem Cell Transplant (ASCT) in Aggressive Non Hodgkin's Lymphoma (NHL).

NCT01296256 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Bendamustine
Conditioning Therapy
Autologous Stem Cell Transplant
Aggressive Non Hodgkin's Lymphoma

Interventions

DRUG: Bendamustine-EAM

Sponsor

Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea